Sosei to repurchase all ¥30 billion 0.25% convertibles due 2026

By Wendy Van Sickle

Columbus, Ohio, Dec. 14 – Sosei Group Corp. will repurchase any and all of its outstanding ¥30 billion of 0.25% convertible bonds due 2026 (ISIN: XS2363140810), according to a notice.

The convertible repurchase was to occur concurrently with the company’s issuance of ¥32 billion of 0.25% convertible bonds due 2028.

The repurchased convertibles will be canceled.

The biopharmaceutical group is based in Tokyo and has research facilities in Cambridge, U.K. Its corporate brand and trademark is Sosei Heptares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.